DK1206268T3 - Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse - Google Patents

Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse

Info

Publication number
DK1206268T3
DK1206268T3 DK00954693T DK00954693T DK1206268T3 DK 1206268 T3 DK1206268 T3 DK 1206268T3 DK 00954693 T DK00954693 T DK 00954693T DK 00954693 T DK00954693 T DK 00954693T DK 1206268 T3 DK1206268 T3 DK 1206268T3
Authority
DK
Denmark
Prior art keywords
biologically active
active agent
preparation
release
compositions
Prior art date
Application number
DK00954693T
Other languages
English (en)
Inventor
Manja Ahola
Eija Saeilynoja
Jukka Salonen
Antti Yli-Urpo
Risto Penttinen
Original Assignee
Bioxid Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioxid Oy filed Critical Bioxid Oy
Application granted granted Critical
Publication of DK1206268T3 publication Critical patent/DK1206268T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00954693T 1999-08-25 2000-08-22 Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse DK1206268T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI19991806A FI19991806A7 (fi) 1999-08-25 1999-08-25 Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus
EP00954693A EP1206268B1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof
PCT/FI2000/000710 WO2001013924A1 (en) 1999-08-25 2000-08-22 Novel compositions for controlled release of a biologically active agent, and the preparation thereof

Publications (1)

Publication Number Publication Date
DK1206268T3 true DK1206268T3 (da) 2005-01-10

Family

ID=8555195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00954693T DK1206268T3 (da) 1999-08-25 2000-08-22 Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse

Country Status (11)

Country Link
US (1) US7112339B1 (da)
EP (1) EP1206268B1 (da)
JP (1) JP2003507427A (da)
AT (1) ATE279928T1 (da)
AU (1) AU6705400A (da)
CA (1) CA2379982A1 (da)
DE (1) DE60015151T2 (da)
DK (1) DK1206268T3 (da)
ES (1) ES2230141T3 (da)
FI (1) FI19991806A7 (da)
WO (1) WO2001013924A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
US7758888B2 (en) 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
CA2442284C (en) * 2001-04-04 2009-10-06 Delsitech Oy Biodegradable carrier and method for preparation thereof
US20030231984A1 (en) * 2002-05-07 2003-12-18 Bright Frank V. Method to rapidly prepare and screen formulations and compositions containing same
DE10249874A1 (de) * 2002-10-25 2004-05-06 Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. Antiadhäsive Beschichtung zur Ausrüstung von Wundverbänden
WO2004081222A2 (en) 2003-03-14 2004-09-23 Sol-Gel Technologies Ltd. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
EA008771B1 (ru) 2003-07-31 2007-08-31 Сол-Джел Текнолоджиз Лтд. Микрокапсулы, заполненные активными ингредиентами, и способ их приготовления
CA2555179A1 (en) * 2004-02-27 2005-09-09 Delsitech Oy Method for preparing adjustably bioresorbable sol-gel derived sio2
GB0420016D0 (en) 2004-09-09 2004-10-13 Leuven K U Res & Dev Controlled release oral delivery system
EP2431089A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
AU2008211554B2 (en) 2007-02-01 2013-12-19 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
US11458105B2 (en) 2008-12-04 2022-10-04 International Flavors & Fragrances Inc. Hybrid fragrance encapsulate formulation and method for using the same
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
KR101070345B1 (ko) 2009-07-03 2011-10-06 서울대학교산학협력단 생체활성인자가 포함된 유무기 혼성 복합 코팅층, 생체 이식용 임플란트 및 그 제조방법
ES2919933T3 (es) * 2011-03-18 2022-07-29 Int Flavors & Fragrances Inc Microcápsulas producidas a partir de precursores de sol-gel combinados y método de producción de las mismas
JP6199883B2 (ja) 2011-12-05 2017-09-20 インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc 医療用オルガノゲルプロセス及び組成物
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
EP3651756B1 (en) 2017-07-12 2025-09-03 Sol-Gel Technologies Ltd. Compositions comprising encapsulated tretinoin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804318A (en) * 1995-10-26 1998-09-08 Corvita Corporation Lubricious hydrogel surface modification
JP3488965B2 (ja) * 1996-05-21 2004-01-19 日本山村硝子株式会社 ゾル−ゲル法による独立膜の製造方法
DE69733889T3 (de) 1996-05-29 2009-10-22 Delsitech Oy Lösliche oxide für biologische anwendungen
WO2000050349A2 (en) * 1999-02-22 2000-08-31 Bioxid Oy Biodegradable ceramic fibres from silica sols

Also Published As

Publication number Publication date
AU6705400A (en) 2001-03-19
FI19991806L (fi) 2001-02-26
JP2003507427A (ja) 2003-02-25
WO2001013924A1 (en) 2001-03-01
EP1206268A1 (en) 2002-05-22
FI19991806A7 (fi) 2001-02-26
DE60015151T2 (de) 2006-02-16
DE60015151D1 (de) 2004-11-25
EP1206268B1 (en) 2004-10-20
US7112339B1 (en) 2006-09-26
ATE279928T1 (de) 2004-11-15
CA2379982A1 (en) 2001-03-01
WO2001013924A8 (en) 2001-11-01
ES2230141T3 (es) 2005-05-01

Similar Documents

Publication Publication Date Title
DK1206268T3 (da) Sammensætninger til frigivelse af et biologisk aktivt middel samt fremstilling af disse
DK1100344T3 (da) Chitosanholdige flydende præparater og fremgangsmåder til deres fremstilling og anvendelse
DK1384478T3 (da) Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
PT1169370E (pt) Solucoes de poliuretano contendo unidades estruturais de alcoxissilano.
IL156306A0 (en) Pyrimidineamines as angiogenesis modulators
AU8841801A (en) Switchable tackiness coating compositions for ophthalmic implants
ATE249486T1 (de) Wässrige reaktive spachtelmassen (i)
AU2003270374A1 (en) Structured liquid fabric treatment compositions
TW200500071A (en) Methods and reagents for treating infections of clostridium difficile and diseases associated therewith
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
WO2003051886A8 (en) Pyrazolopyridazine derivatives
WO2003017990A3 (en) Ophthalmic composition comprising an ascomycin
WO2003017924A3 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
WO2003062443A3 (en) Novel substituted alkane compounds and uses thereof
WO2003057149A3 (en) 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
EP1040858A3 (en) Antifoam compositions
WO2001087063A3 (en) Agricultural compositions employing organosiloxanes containing polyhydric groups
BR0213246A (pt) Composição aquosa, método para tratar um substrato poroso, artigo, e, composição resistente a mancha
DE60007300D1 (de) Schaumregulierungsmittel für silikontenside
WO2000040232A3 (en) Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
TR200003794T2 (tr) Kaplama amilleri ve bunların kullanımı.
NO20002408L (no) 5-HT1F antagonister
DE60123103D1 (de) Neue verbindungen
ATE302223T1 (de) Isocyanato-oligourethane